ADAR1 Capital Management »

Journey Med Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Journey Med Corp (DERM) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Journey Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Journey Med Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Journey Med Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $280k 40k 7.08

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Journey Med Corp

Daniel D. Thurber
Tang Capital Management
Vanguard Capital Management
Punch & Associates Investment Management
Pale Fire Capital SE
Opaleye Management
Jane Street
Summit Financial
Diametric Capital
Ikarian Capital
State Street Corporation
Renaissance Technologies
Geode Capital Management
American Financial Group
Trexquant Investment

View all funds holding Journey Med Corp